<DOC>
	<DOCNO>NCT01644435</DOCNO>
	<brief_summary>This multicentre , open label , randomize , pilot study evaluate safety efficacy Human Platelet Lysate ( HPL ) subject Acne Scarring . The study conduct 2 center India . The primary endpoint change Global Acne scar classification score screen end study . The secondary endpoint Photographic Assessment , Physicians assessment score Patients self assessment score .</brief_summary>
	<brief_title>A Pilot Study Determine Safety &amp; Efficacy Autologous Human Platelet Lysate ( HPL ) Treatment Acne Scarring</brief_title>
	<detailed_description />
	<mesh_term>Cicatrix</mesh_term>
	<criteria>Subjects ( male female ) , age 18 40 year ( inclusive ) . Subject willing refrain treatment Acne Scarring entire study duration . Nonpregnant , nonlactating female agree use adequate acceptable method contraception screen throughout course study . Subjects willing give inform consent adhere study protocol . Subjects active infection active acne . Subjects receive treatment : NSAIDs treatment within last 7 day prior study . Subjects history connective tissue disease . Subjects metabolic hematopoietic disorder . Subjects know bleed disorder platelet dysfunction syndrome , thrombocytopenia , hypofibrinogenemia . Subjects receive prior chemotherapy radiotherapy Subjects unwilling unable comply study protocol . Subjects take concomitant therapy might interfere study result investigator 's opinion participate another trial past 30days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>